Current Evidence of Interleukin-6 Signaling Inhibitors in Patients With COVID-19: A Systematic Review and Meta-Analysis

Background: Interleukin-6 (IL-6) is known to be detrimental in coronavirus disease 2019 (COVID-19) because of its involvement in driving cytokine storm. This systematic review and meta-analysis aimed to assess the safety and efficacy of anti-IL-6 signaling (anti-IL6/IL-6R/JAK) agents on COVID-19 bas...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Qi Han (Author), Mingyue Guo (Author), Yue Zheng (Author), Ying Zhang (Author), Yanshan De (Author), Changchang Xu (Author), Lin Zhang (Author), Ruru Sun (Author), Ying Lv (Author), Yan Liang (Author), Feng Xu (Author), Jiaojiao Pang (Author), Yuguo Chen (Author)
Formato: Libro
Publicado: Frontiers Media S.A., 2020-12-01T00:00:00Z.
Subjects:
Acceso en liña:Connect to this object online.
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Internet

Connect to this object online.

3rd Floor Main Library

Detalle de Existencias desde 3rd Floor Main Library
Número de Clasificación: A1234.567
Copia 1 Dispoñible